Markets:

Overview

News

Currencies

International

Treasuries

Amneal Pharmaceuticals, Inc. - Class A Common Stock (NY:AMRX)

N/A UNCHANGED

Last Price Updated: 7:00 PM EST, Dec 26, 2023 Add to My Watchlist

Quote

Overview Detailed Quote Charting Historical Prices

News

All News News Headlines Press Releases

Research

Quarterly Reports Insider Filings Other Filings

All News about Amneal Pharmaceuticals, Inc. - Class A Common Stock

< Previous 1 2 3 4 5 6 7 Next >

Why Asbury Automotive Group Shares Are Trading Lower By Over 6%? Here Are Other Stocks Moving In Tuesday's Mid-Day Session ↗

October 24, 2023

Gainers InMed Pharmaceuticals Inc. (NASDAQ: INM) shares climbed 169% to $1.56 after the company announced it selected a lead Alzheimer's drug candidate following proof-of-concept study data.

Via Benzinga

General Electric, Verizon, Cleveland-Cliffs And Other Big Stocks Moving Higher On Tuesday ↗

October 24, 2023

U.S. stocks traded higher Tuesday, with the Nasdaq Composite gaining over 100 points. Here are some big stocks recording gains in the trading session. ImmunityBio, Inc. (NASDAQ: IBRX) shares rose...

Via Benzinga

Topics Stocks

12 Health Care Stocks Moving In Monday's After-Market Session ↗

October 23, 2023

Via Benzinga

Amneal Reports Certain Preliminary Third Quarter 2023 Financial Results and Raises Full Year 2023 Financial Guidance

October 23, 2023

From Amneal Pharmaceuticals, Inc.

Via Business Wire

Amneal Adds Two Denosumab Biosimilars to U.S. Pipeline, Expanding Oncology Portfolio

October 12, 2023

From Amneal Pharmaceuticals, Inc.

Via Business Wire

NuScale Power, Stagwell And Other Big Stocks Moving Higher On Friday ↗

October 06, 2023

U.S. stocks traded higher, with the Nasdaq Composite gaining around 50 points on Friday. Here are some big stocks recording gains in Friday's session.

Via Benzinga

Topics Stocks

Analyst Ratings for Amneal Pharmaceuticals ↗

September 06, 2023

Via Benzinga

Amneal Pharmaceuticals's Earnings: A Preview ↗

August 03, 2023

Via Benzinga

Why Shares of Amneal Pharmaceuticals Are Plunging Wednesday ↗

July 05, 2023

The company received a complete response letter from the FDA regarding a Parkinson's disease generic therapy.

Via The Motley Fool

Amneal to Report Third Quarter 2023 Results on November 7, 2023

October 05, 2023

From Amneal Pharmaceuticals, Inc.

Via Business Wire

Amneal Receives U.S. FDA Approval for Calcium Gluconate Injection

September 06, 2023

From Amneal Pharmaceuticals, Inc.

Via Business Wire

Amneal Receives First Product Approval in China

September 06, 2023

From Amneal Pharmaceuticals, Inc.

Via Business Wire

Amneal Receives U.S. FDA Approval for Lisdexamfetamine Dimesylate

September 06, 2023

From Amneal Pharmaceuticals, Inc.

Via Business Wire

Delegation from U.S. Department of Health and Human Services, U.S. Food and Drug Administration, and Local Government Officials Visit Amneal Manufacturing Site in India

August 29, 2023

From Amneal Pharmaceuticals, Inc.

Via Business Wire

Amneal to Participate at the 2023 Wells Fargo Healthcare Conference

August 25, 2023

From Amneal Pharmaceuticals, Inc.

Via Business Wire

JAMA Neurology Publishes Phase 3 Study Results Comparing IPX203 to Immediate-Release Carbidopa/Levodopa for Parkinson’s Disease

August 24, 2023

From Amneal Pharmaceuticals, Inc.

Via Business Wire

12 Health Care Stocks Moving In Friday's Intraday Session ↗

August 04, 2023

Via Benzinga

Why ResMed Shares Are Trading Lower By 15%? Here Are Other Stocks Moving In Friday's Mid-Day Session ↗

August 04, 2023

Gainers Missfresh Limited (NASDAQ: MF) jumped 168% to $1.38 after the company announced entry of share purchase agreements for financing and business acquisition.

Via Benzinga

Atlassian, Universal Display, Booking, Dropbox And Other Big Stocks Moving Higher On Friday ↗

August 04, 2023

U.S. stocks traded higher, with the Dow Jones gaining around 150 points on Friday. Here are some big stocks recording gains in today’s session.

Via Benzinga

Amneal Pharmaceuticals Stock Gaines: It Raised FY23 Outlook On Prescription Trends, Pricing Levels Strength ↗

August 04, 2023

Amneal Pharmaceuticals Inc (NYSE: AMRX) reports Q2 revenue of $599 million, an increase of 7% Y/Y, beating the consensus of $5

Via Benzinga

Amneal Reports Second Quarter 2023 Financial Results

August 04, 2023

From Amneal Pharmaceuticals, Inc.

Via Business Wire

Earnings Scheduled For August 4, 2023 ↗

August 04, 2023

Companies Reporting Before The Bell • WPP (NYSE:WPP) is projected to report earnings for its first quarter. • Anglogold Ashanti (NYSE:AU) is likely to report earnings for its first quarter.

Via Benzinga

Amneal Submits Abbreviated New Drug Applications to U.S. FDA for Three Key Complex Generics

July 26, 2023

From Amneal Pharmaceuticals, Inc.

Via Business Wire

Amneal to Report Second Quarter 2023 Results on August 4, 2023

July 06, 2023

From Amneal Pharmaceuticals, Inc.

Via Business Wire

Crude Oil Rises Sharply; Impel Pharmaceuticals Shares Spike Higher ↗

July 05, 2023

U.S. stocks traded lower midway through trading, with the Dow Jones dropping over 50 points on Wednesday. The Dow traded down 0.17% to 34,361.31 while the NASDAQ fell 0.14% to 13,797.72. The S&P 500,...

Via Benzinga

Dow Drops 150 Points; US Factory Orders Increase 0.3% In May ↗

July 05, 2023

U.S. stocks traded lower this morning, with the Dow Jones dropping over 150 points on Wednesday. Following the market opening Wednesday, the Dow traded down 0.46% to 34,259.45 while the NASDAQ fell...

Via Benzinga

Why 1847 Holdings Shares Are Trading Lower By Around 31%? Here Are Other Stocks Moving In Wednesday's Mid-Day Session ↗

July 05, 2023

Gainers Allarity Therapeutics, Inc. (NASDAQ: ALLR) shares surged 87% to $11.78 after the company said the initial data from Phase 2 trial of Ixempra shows potential for improved clinical benefit in...

Via Benzinga

12 Health Care Stocks Moving In Wednesday's Pre-Market Session ↗

July 05, 2023

Via Benzinga

FDA Strikes Out Amneal Pharmaceuticals' Parkinson's Disease Candidate, Stock Falls ↗

July 05, 2023

Amneal Pharmaceuticals Inc (NYSE: AMRX) received an FDA Complete Response Letter (CRL) regarding its New Drug Application for IPX203

Via Benzinga

12 Health Care Stocks Moving In Tuesday's After-Market Session ↗

July 04, 2023

Via Benzinga

< Previous 1 2 3 4 5 6 7 Next >

Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.

Amneal Pharmaceuticals, Inc. - Class A Common Stock (NY:AMRX)

All News about Amneal Pharmaceuticals, Inc. - Class A Common Stock

Starting at /week.